i'm back, page-6

Excella
these are phase 1 trials. The only conclusions are safety
and efficacy ie that they can be given safely
so far this has been the case and I imagine will
be the same for the head And neck trials
the phase 2 trials are to work out the correct dosage
and monitor results
there is no reason that this drug will not be used in some
capacity particularly since the side effects have been
negligible to date and results encouraging for all the oncoviruses
to date
even if they have partial responses with the minimal toxicity
these drugs will be used
and that equals big bucks
when phase two trials are concluded this little babe will be taken over
by a large pharma company
good luck to all long termers
BD